SAH (SUBARACHNOID HEMORRHAGE)
Clinical trials for SAH (SUBARACHNOID HEMORRHAGE) explained in plain language.
Never miss a new study
Get alerted when new SAH (SUBARACHNOID HEMORRHAGE) trials appear
Sign up with your email to follow new studies for SAH (SUBARACHNOID HEMORRHAGE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cystic fibrosis drug help brain bleed survivors walk again?
Disease control Recruiting nowThis study tests whether a daily IV dose of dornase alfa (a drug currently used for cystic fibrosis) given for up to 14 days after a brain aneurysm rupture can help patients regain independence at 6 months. The drug targets tiny blood clots and inflammation in the brain that ofte…
Matched conditions: SAH (SUBARACHNOID HEMORRHAGE)
Phase: PHASE2 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Nose spray nerve block may ease brain bleed headaches, cut opioid use
Symptom relief Recruiting nowThis study tests whether a numbing injection through the nose can better relieve severe headaches caused by a brain bleed (subarachnoid hemorrhage). About 40 adults with a secured aneurysm will receive either the nerve block plus standard pain meds or standard meds alone. The goa…
Matched conditions: SAH (SUBARACHNOID HEMORRHAGE)
Phase: PHASE2, PHASE3 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated May 26, 2026 07:35 UTC